Page last updated: 2024-10-31

methyl methanesulfonate and Esophageal Neoplasms

methyl methanesulfonate has been researched along with Esophageal Neoplasms in 3 studies

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Zang, W1
Du, Y1
Chen, X1
Zhao, G1
Barnas, C1
Martel-Planche, G1
Furukawa, Y1
Hollstein, M1
Montesano, R1
Hainaut, P1
Sheikh, MS1
Huang, Y1
Fernandez-Salas, EA1
El-Deiry, WS1
Friess, H1
Amundson, S1
Yin, J1
Meltzer, SJ1
Holbrook, NJ1
Fornace, AJ1

Other Studies

3 other studies available for methyl methanesulfonate and Esophageal Neoplasms

ArticleYear
The K167I variant of DNA polymerase β that is found in Esophageal Carcinoma patients impairs polymerase activity and BER.
    Scientific reports, 2015, Nov-03, Volume: 5

    Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Survival;

2015
Inactivation of the p53 protein in cell lines derived from human esophageal cancers.
    International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1

    Topics: Base Sequence; Blotting, Western; DNA; DNA Damage; Esophageal Neoplasms; Humans; Hydrogen Peroxide;

1997
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
    Oncogene, 1999, Jul-15, Volume: 18, Issue:28

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma;

1999